RFQ Human Cytokine/Chemokine/Growth Factor Panel A

SOL #: 75N98026Q00516Combined Synopsis/Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

Place of performance not available

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 4, 2026
2
Submission Deadline
Jun 18, 2026, 9:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), specifically the National Institute of Mental Health (NIMH), is seeking proposals for Human Cytokine/Chemokine/Growth Factor Panel A Immunoassay Kits and related verification/calibration kits. This combined synopsis/solicitation aims to procure biological laboratory supplies for analyzing proteins in blood samples to explore biomarkers in mood disorders and the effects of novel anti-depressants. Proposals are due June 18, 2026, at 5:30 pm EDT.

Scope of Work

The requirement is for the supply of:

  • Four (4) Human Cytokine/Chemokine/Growth Factor Panel A 48 Plex Immunoassay Kits.
  • One (1) MPXPVER-K25 MAGPIX Performance Verification Kit.
  • One (1) MPXCAL-K25 MAGPIX Calibration Kit. The immunoassay kits must be designed from analytically validated panels, have standardized and fixed standard curve ranges, and consistent standard concentrations across all analytes for quantitative assays. These kits will be used at the National Institutes of Health – NIMH, Bethesda, MD.

Contract Details

  • Type: Combined Synopsis/Solicitation (RFQ) for commercial items.
  • Acquisition Method: Conducted under FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and expected to be under the simplified acquisition threshold.
  • Set-Aside: Unrestricted.
  • Applicable Clauses: Provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01 will be included.

Submission & Evaluation

  • Proposal Due: June 18, 2026, at 5:30 pm EDT.
  • Submission Method: Responses must be submitted via the SAM.gov webportal.
  • Required Information: Unit and total price, shipping and handling costs, delivery period after award, delivery terms, F.O.B. point, product/catalog numbers, and a detailed product/service description. Offerors must also include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items.
  • Evaluation Factors: Price, Technical capability, Past performance, and Delivery schedule.

Eligibility

  • This requirement is unrestricted.
  • All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.
  • Offerors must include their Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification.

Additional Notes

  • Solicitation Number: 75N98026Q00516.
  • Point of Contact: Brittany May, Contract Specialist, at brittany.may@nih.gov.
  • The Defense Priorities and Allocations System (DPAS) is not applicable.

People

Points of Contact

Files

Files

Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jun 4, 2026
RFQ Human Cytokine/Chemokine/Growth Factor Panel A | GovScope